Canada Pension Plan Investment Board’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-204,900	Closed	-$29.9M	–	1352
2022 Q2	$29.9M	Buy	+204,900	New	+$26.2M	0.05%	280
2022 Q1	–	Sell	-752	Closed	-$104K	–	1668
2021 Q4	$104K	Buy	+752	New	+$95.6K	﹤0.01%	1335
2021 Q2	–	Sell	-106	Closed	-$7K	–	1460
2021 Q1	$7K	Sell	106 -257	-71%	-$20.8K	﹤0.01%	1236
2020 Q4	$31K	Buy	363 +198	+120%	+$16.8K	﹤0.01%	1296
2020 Q3	$11K	Buy	+165	New	+$10.8K	﹤0.01%	1049

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Canada Pension Plan Investment Board's BHVN Position: Q3 2022 in Review

Canada Pension Plan Investment Board sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 204,900 shares — an estimated $29.9M sold.

Canada Pension Plan Investment Board first reported a position in BHVN in Q3 2020 and held it in 5 quarters. The position peaked at $29.9M in Q2 2022. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

Canada Pension Plan Investment Board reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
Canada Pension Plan Investment Board sold 204,900 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $29.9M.
Canada Pension Plan Investment Board first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2020 and held it in 5 quarters.
Canada Pension Plan Investment Board's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $29.9M in Q2 2022.
240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2022, filed 14 Nov 2022.